Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Biotek-snakken
  4. Biotek-snakken — Februar 2023

Biotek-snakken — Februar 2023

Planlagt Fastgjort Låst Flyttet Biotek-snakken
127 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • The_DudeT Offline
    The_DudeT Offline
    The_Dude
    wrote on sidst redigeret af
    #118

    Penser Bank - kender ikke deres troværdighed - har lavet en note. Og der guider de en pæn kursstigning fra de nuværende ca. 100 SEK. Men de nævnet også et studie i marts, som de mener får afgørende betydning for kursen. Igen, er her nogen der er godt unde i casen?

    https://docs.penser.se/a/3538/CALTX20230224_PDF.pdf

    1 Reply Last reply
    0
    • F Offline
      F Offline
      Fandel
      wrote on sidst redigeret af
      #119

      Godmorgen...

      1 Reply Last reply
      0
      • F Offline
        F Offline
        Fandel
        wrote on sidst redigeret af
        #120

        Godmorgen...

        1 Reply Last reply
        0
        • P Offline
          P Offline
          ProinvestorNEWS
          wrote on sidst redigeret af
          #121

          3 Biotech Stocks To Watch Ahead Of March 2023 https://www.proinvestor.com/investornyt/946791/3-biotech-stocks-to-watch-ahead-of-march-2023

          1 Reply Last reply
          0
          • F Offline
            F Offline
            Fandel
            wrote on sidst redigeret af
            #122

            Godmorgen...

            1 Reply Last reply
            0
            • DarvinD Offline
              DarvinD Offline
              Darvin
              wrote on sidst redigeret af
              #123

              Har skrevet om Fluoguide og ligeledes Curasight tidligere. Og at Curasight har noget rigtig godt at vente på/i hente. Stiger 13% idag ved regnskab, og håber nogle er med. SEB kommenterer og siger pt valuering
              på 54 mod dagens ca 13

              1 Reply Last reply
              0
              • F Offline
                F Offline
                Fandel
                wrote on sidst redigeret af
                #124

                Godmorgen...

                1 Reply Last reply
                0
                • B Offline
                  B Offline
                  bibob
                  wrote on sidst redigeret af
                  #125

                  Fluoguide bliver forsinket med resultater fra hovedaktiv. ( MedWatch )

                  1 Reply Last reply
                  0
                  • L Offline
                    L Offline
                    LP90
                    wrote on sidst redigeret af
                    #126

                    Godmorgen 🙂

                    1 Reply Last reply
                    0
                    • P Offline
                      P Offline
                      ProinvestorNEWS
                      wrote on sidst redigeret af
                      #127

                      Biogen Says BLA For Lecanemab Gets Priority Review By NMPA In China https://www.proinvestor.com/investornyt/947553/biogen-says-bla-for-lecanemab-gets-priority-review-by-nmpa-in-china

                      1 Reply Last reply
                      0
                      • P Offline
                        P Offline
                        ProinvestorNEWS
                        wrote on sidst redigeret af
                        #128

                        Biotech Stocks Facing FDA Decision In March 2023 https://www.proinvestor.com/investornyt/947570/biotech-stocks-facing-fda-decision-in-march-2023

                        1 Reply Last reply
                        0

                        Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                        Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                        With your input, this post could be even better 💗

                        Tilmeld Log ind
                        Svar
                        • Svar som emne
                        Login for at svare
                        • Ældste til nyeste
                        • Nyeste til ældste
                        • Most Votes


                        • Log ind

                        • Har du ikke en konto? Tilmeld

                        • Login or register to search.
                        Powered by NodeBB Contributors
                        • First post
                          Last post
                        0
                        • Kategorier
                        • Seneste
                        • Etiketter
                        • Populære
                        • Verden
                        • Bruger
                        • Grupper